Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin for Post-Operative Atrial Fibrillation in CABG
NCT06124937Phase 3Unknown
- Sponsor
- Rajaie Cardiovascular Medical and Research Center
- Start
- Nov 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of empagliflozin in Atrial fibrillation (AFib), sponsored by Rajaie Cardiovascular Medical and Research Center. Status: unknown.
02
Drugs
empagliflozin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT06124937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06124937.